Stock comparison
AbbVie Inc. is 49.1x more valuable than Alkermes plc. by market capitalization ($440.14 B vs $8.96 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 49.1x more valuable than Alkermes plc. by market capitalization ($440.14 B vs $8.96 B).
Market value leader
ABBV
AbbVie Inc. is 49.1x more valuable than Alkermes plc. by market capitalization ($440.14 B vs $8.96 B).
Revenue leader
ABBV
ALKS: $1.48B vs ABBV: $61.16B.
Profit leader
ABBV
ALKS: $241.70M vs ABBV: $4.23B.
Margin leader
ALKS
ALKS: 16.4% vs ABBV: 6.9% net margin.
| Metric | ALKS | ABBV |
|---|---|---|
| Market cap | $8.96 B | $440.14 B |
| US-listed rank | #1026 | #25 |
| Revenue (latest FY) | $1.48B | $61.16B |
| Net income (latest FY) | $241.70M | $4.23B |
| Net margin | 16.4% | 6.9% |
| P/E (trailing FY) | 37.1x | 104.2x |
| SEC filings | 1,884 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 49.1x more valuable than Alkermes plc. by market capitalization ($440.14 B vs $8.96 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Alkermes plc. and AbbVie Inc., or browse the full rankings.